ChineseInvestors.com (CIIX) Eyes Expansion in CBD Markets throughout North America
- Sees opportunities in the fast-growing international medical marijuana market
- Plans store opening in San Gabriel, California, with online hemp-based product store already in Shanghai, China, targeting the global Chinese-speaking community
- Consilium Global Research projects that company revenues will reach $14.8 million by FY2020
ChineseInvestors.com, Inc. (OTCQB: CIIX) is employing a strategy of selling cannabidiol (CBD) in North America. It plans for a brick-and-mortar store in San Gabriel, California, as well as recently incorporating CBD Biotechnology, Inc., in British Columbia, Canada. It also has an online CBD store with hemp-based products located in the free trade zone of Shanghai, China, designed to serve the global Chinese-speaking population.
CIIX offers educational and consulting services to the Chinese community. Most recently, it has been pursuing the hemp oil-based industry through its online store, its planned California unit, and now the corporation formation in Canada. The goal of the company is to be the leading Chinese publicly-traded nutritional company. CIIX is projected to reach eight-figure revenues by FY2020, according to a SeeThruEquity research report (http://nnw.fm/27PnD), and it is still working its core, high-margin investor relations business within the Chinese-speaking market.
However, its expansion into Canada illustrates that CIIX is eyeing, in addition to hemp-based nutritional products, opportunities in the medical marijuana market. Warren Wang, founder and chief executive officer of CIIX, said the incorporation of CBD Biotechnology in Canada is a “promising step forward” toward the company’s goals of entering the medical marijuana industry. He noted that there are nearly one million Chinese in Canada.
Investor relations and subscription levels continue to grow, the SeeThruEquity report noted, giving CIIX a foothold within the Chinese-speaking community. A research report by Consilium Global Research (http://nnw.fm/U2Zvi) added that CIIX’s intimate knowledge and penetration of the native Chinese market in the U.S. and globally, “makes for an enormous and niche opportunity.” It projects company sales reaching $14.8 million by FY2020.
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Sees opportunities in the fast-growing international medical marijuana market
- Plans store opening in San Gabriel, California, with online hemp-based product store already in Shanghai, China, targeting the global Chinese-speaking community
- Consilium Global Research projects that company revenues will reach $14.8 million by FY2020
ChineseInvestors.com, Inc. (OTCQB: CIIX) is employing a strategy of selling cannabidiol (CBD) in North America. It plans for a brick-and-mortar store in San Gabriel, California, as well as recently incorporating CBD Biotechnology, Inc., in British Columbia, Canada. It also has an online CBD store with hemp-based products located in the free trade zone of Shanghai, China, designed to serve the global Chinese-speaking population.
CIIX offers educational and consulting services to the Chinese community. Most recently, it has been pursuing the hemp oil-based industry through its online store, its planned California unit, and now the corporation formation in Canada. The goal of the company is to be the leading Chinese publicly-traded nutritional company. CIIX is projected to reach eight-figure revenues by FY2020, according to a SeeThruEquity research report (http://nnw.fm/27PnD), and it is still working its core, high-margin investor relations business within the Chinese-speaking market.
However, its expansion into Canada illustrates that CIIX is eyeing, in addition to hemp-based nutritional products, opportunities in the medical marijuana market. Warren Wang, founder and chief executive officer of CIIX, said the incorporation of CBD Biotechnology in Canada is a “promising step forward” toward the company’s goals of entering the medical marijuana industry. He noted that there are nearly one million Chinese in Canada.
Investor relations and subscription levels continue to grow, the SeeThruEquity report noted, giving CIIX a foothold within the Chinese-speaking community. A research report by Consilium Global Research (http://nnw.fm/U2Zvi) added that CIIX’s intimate knowledge and penetration of the native Chinese market in the U.S. and globally, “makes for an enormous and niche opportunity.” It projects company sales reaching $14.8 million by FY2020.
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
